Clinical and morphological basis of acute respiratory distress syndrome
Автор: Sodikova Dilrabo Tozhidinovna, Nazarova Gulchehra Usmanovna
Журнал: Re-health journal.
Статья в выпуске: 1 (21), 2024 года.
Бесплатный доступ
In December 2019, a new infectious disease epidemic began in China, which quickly assumed an unprecedented, planetary scale. The cause of the pandemic was another member of the coronavirus family, SARS-Cov-2. The disease was officially named COVID-19. COVID-19 is usually manifested by signs of respiratory damage, but to consider it as a local respiratory disease would be an oversimplification. Its manifestations can be seen as a combination of two processes, namely viral pneumonia and ARDS. Along with other serious coronavirus infections SARS and MERS, which also cause ARDS, COVID-19 is an ongoing global threat because this virus family can mutate and infect unimmunized populations. Even in the mild form of COVID-19, the nervous system is damaged early and often, and the intestines are frequently infected. At the same time, the risk of spreading the infectious process and developing severe systemic disease is mainly associated with lung lesions.
COVID-19, endothelium, pneumonia, distress syndrome, lung, fibrosis, fibrin
Короткий адрес: https://sciup.org/14130747
IDR: 14130747